Abiopharma

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff and Torok’s Short-Sighted Campaign

Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer

VENU Plans $80 Million Sale-Leaseback Financing for Parking Garage Asset at Sunset Amphitheater in McKinney, Texas

Electronic Arts Introduces EA Advertising, Launching Brands Directly Into Gameplay and Live Experiences

IREN Completes Acquisition of Nostrum Group Expanding AI Cloud Platform to Europe

Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe

Sherritt Announces Exclusivity Agreement with Gillon Capital and Appointment of Independent Director

OTC Markets Group Names Thomas Fasano Head of Broker-Dealer Sales

Pebblebrook Hotel Trust Declares Dividends for Second Quarter 2026

Natural Gas Services Group Acquires Flatrock Compression